1. Home
  2. CREX vs THAR Comparison

CREX vs THAR Comparison

Compare CREX & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREX
  • THAR
  • Stock Information
  • Founded
  • CREX N/A
  • THAR 2017
  • Country
  • CREX United States
  • THAR United States
  • Employees
  • CREX N/A
  • THAR N/A
  • Industry
  • CREX EDP Services
  • THAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CREX Technology
  • THAR Health Care
  • Exchange
  • CREX Nasdaq
  • THAR Nasdaq
  • Market Cap
  • CREX 25.7M
  • THAR 22.8M
  • IPO Year
  • CREX N/A
  • THAR 2022
  • Fundamental
  • Price
  • CREX $3.18
  • THAR $3.10
  • Analyst Decision
  • CREX Strong Buy
  • THAR Strong Buy
  • Analyst Count
  • CREX 1
  • THAR 1
  • Target Price
  • CREX $6.00
  • THAR $17.00
  • AVG Volume (30 Days)
  • CREX 108.6K
  • THAR 268.9K
  • Earning Date
  • CREX 11-12-2025
  • THAR 11-07-2025
  • Dividend Yield
  • CREX N/A
  • THAR N/A
  • EPS Growth
  • CREX N/A
  • THAR N/A
  • EPS
  • CREX N/A
  • THAR N/A
  • Revenue
  • CREX $48,218,000.00
  • THAR N/A
  • Revenue This Year
  • CREX $3.52
  • THAR N/A
  • Revenue Next Year
  • CREX $20.10
  • THAR N/A
  • P/E Ratio
  • CREX N/A
  • THAR N/A
  • Revenue Growth
  • CREX N/A
  • THAR N/A
  • 52 Week Low
  • CREX $1.28
  • THAR $0.95
  • 52 Week High
  • CREX $4.72
  • THAR $9.08
  • Technical
  • Relative Strength Index (RSI)
  • CREX 70.26
  • THAR 52.96
  • Support Level
  • CREX $2.70
  • THAR $2.68
  • Resistance Level
  • CREX $3.00
  • THAR $3.18
  • Average True Range (ATR)
  • CREX 0.30
  • THAR 0.29
  • MACD
  • CREX 0.07
  • THAR 0.01
  • Stochastic Oscillator
  • CREX 84.62
  • THAR 60.90

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: